These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32067633)

  • 1. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
    Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
    Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial.
    Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Biannual Azithromycin on Anemia in Preschool Children in Kilosa District, Tanzania: A Cluster-Randomized Clinical Trial.
    Bloch EM; Munoz B; Weaver J; Mrango Z; Lietman TM; West SK
    Am J Trop Med Hyg; 2020 Sep; 103(3):1311-1314. PubMed ID: 32067629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
    Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T;
    PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
    Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
    Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial.
    Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution.
    Oldenburg CE; Arzika AM; Maliki R; Lin Y; O'Brien KS; Keenan JD; Lietman TM; For The Mordor Study Group
    Am J Trop Med Hyg; 2020 Sep; 103(3):1308-1310. PubMed ID: 32067626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of nasopharyngeal
    Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
    Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial.
    Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.
    Keenan JD; Arzika AM; Maliki R; Boubacar N; Elh Adamou S; Moussa Ali M; Cook C; Lebas E; Lin Y; Ray KJ; O'Brien KS; Doan T; Oldenburg CE; Callahan EK; Emerson PM; Porco TC; Lietman TM
    N Engl J Med; 2019 Jun; 380(23):2207-2214. PubMed ID: 31167050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial.
    Oron AP; Burstein R; Mercer LD; Arzika AM; Kalua K; Mrango Z; West SK; Bailey RL; Porco TC; Lietman TM
    Am J Trop Med Hyg; 2020 Sep; 103(3):1295-1300. PubMed ID: 30734696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cross-Sectional Study of the Availability of Azithromycin in Local Pharmacies and Associated Antibiotic Resistance in Communities in Kilosa District, Tanzania.
    Ansah D; Weaver J; Munoz B; Bloch EM; Coles CL; Lietman T; West SK
    Am J Trop Med Hyg; 2019 May; 100(5):1105-1109. PubMed ID: 30915951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Biannual Azithromycin to Children under 5 Years on the Carriage of Respiratory Pathogens among Children Aged 7-11 Years.
    Brennhofer SA; Rogawski McQuade ET; Zhang J; Pholwat S; Stroup S; Platts-Mills JA; Liu J; Houpt ER
    Am J Trop Med Hyg; 2023 Feb; 108(2):428-432. PubMed ID: 36535258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger: A Secondary Analysis of the MORDOR Cluster Randomized Trial.
    Chao DL; Arzika AM; Abdou A; Maliki R; Karamba A; Galo N; Beidi D; Harouna N; Abarchi M; Root E; Mishra A; Lebas E; Arnold BF; Oldenburg CE; Keenan JD; Lietman TM; O'Brien KS
    JAMA Netw Open; 2023 Dec; 6(12):e2346840. PubMed ID: 38100110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial.
    Bloch EM; Mrango Z; Weaver J; Munoz B; Lietman TM; West SK
    PLoS One; 2021; 16(9):e0250197. PubMed ID: 34559801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial.
    Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM;
    Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.
    Burr SE; Milne S; Jafali J; Bojang E; Rajasekhar M; Hart J; Harding-Esch EM; Holland MJ; Mabey DC; Sillah A; Bailey RL; Roca A
    Bull World Health Organ; 2014 Jul; 92(7):490-8. PubMed ID: 25110374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Impact of Oral Azithromycin Taken by Gambian Women During Labor on Prevalence and Antibiotic Susceptibility of Streptococcus pneumoniae and Staphylococcus aureus in Their Infants: Follow-up of a Randomized Clinical Trial.
    Bojang A; Camara B; Jagne Cox I; Oluwalana C; Lette K; Usuf E; Bottomley C; Howden BP; D'Alessandro U; Roca A
    Clin Infect Dis; 2018 Sep; 67(8):1191-1197. PubMed ID: 29608659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study.
    Bloch EM; Munoz B; Mrango Z; Weaver J; Mboera LEG; Lietman TM; Sullivan DJ; West SK
    Malar J; 2019 Aug; 18(1):284. PubMed ID: 31443654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.